Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Orient Pharma Co., Ltd.

NCT04643093 is registered in ClinicalTrials.gov with Orient Pharma Co., Ltd. as lead sponsor.

NCT NCT04643093
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04643093 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Orient Pharma Co., Ltd.
Lead sponsor
Orient Pharma Co., Ltd.
Phase
Phase 3
Overall status
Completed
Start date
August 1, 2020
Completion date
October 5, 2021
Enrollment
390 (actual)
Sites
34

Conditions

As the registry lists them; a condition with its own page is linked.

mixed dyslipidemias, primary hypercholesterolemia